Furthermore, high levels of JMJD6 mRNA expression in the 405 MYCN-non-amplified and the 66 MYCN-amplified neuroblastoma tissues were also positively associated with poor patient overall survival in the large Oberthuer dataset (Fig. 1f). The gene discussed is JMJD6; the disease is neuroblastoma.